EN DE
Watch Haidemenos S.A. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Haidemenos S.A. (HAIDE) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Haidemenos S.A. stock €1.09, price €1.17, that is 6.8% below the price, quality 54 out of 100. Rating: fairly valued. Calculated from audited financials with 3 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials GR · ISIN GRS350263000

HS Haidemenos S.A. logo Thin data Nov 4, 2026

Haidemenos S.A.

HAIDE · AT
Fairly valued, sideways

The stock costs about what our calculation considers fair.

Revenue last quarter +21% vs. a year ago.
Fair value €1.09 · Fairly valued
Quality 54/100
Expensive Growth (revenue 5y +5.3 %/yr in EUR)
Thin margins · 3.3% net margin (TTM)
Mixed vs. peers (5/10)
Negative free cash flow
Narrow moat 30/100 · thin data
Thin data
Watch Haidemenos S.A. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€1.17 €0.4020 Fair Value €1.09 Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

60‑month range €0.4020 – €1.17 · fair‑value band €0.7800 – €1.56 · the €1.17 price screens above the €1.09 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.

Follow Haidemenos in your weekly email

Every Wednesday you see whether Haidemenos is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Haidemenos S.A. operates as a printing company in Europe and Africa.

Show moreShow less

It offers magazine and newspaper, catalog, and book printing services; commercial printing services comprising catalogs, flyers, sales and promotional materials, loyalty programms, newsletters, annual reports, signage, indoor and outdoor banners, stands, floor graphics, and window printing solutions.

In addition, it offers promotional and POP stands; retail insert printing solutions; and outdoor printing solutions. The company also provides digital printing services.

It serves retail, IT, electronics, communication, automotive, hospitality, consumer goods, publishing, fashion and clothing, and entertainment industries, as well as AD agencies; health, insurance, and pharmaceutical companies; shopping malls; and organizations like airports, museums, confederations, and foundations.

Haidemenos S.A. was founded in 1976 and is based in Athens, Greece.

Stock analysis

Haidemenos S.A. (HAIDE) currently trades at €1.17, while our model-based Fair Value estimate is €1.09, so the stock looks roughly fairly valued today (gap 7.3%).

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €1.31 per share, and 1 of the 3 models we run sit above the €1.17 price.

Bear case: the Asset-Based group reads lowest at €1.05, and 2 of the 3 models stay below the price. Data coverage for this calculation is low.

Scenario range: €0.7800 (bear) to €1.56 (bull), the price of €1.17 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Haidemenos S.A. reported revenue of €17.8M in FY2025 versus €15.0M in FY2021, a compound +4.5%/yr. Reported net income was −€362K in FY2025.

Key figures

Market cap €9.8M Micro · P/S ratio 0.41 · EPS (TTM) €−0.1540 · Net margin −2.0% · Return on equity 4.8% · Return on assets (EBIT) −2.8% (5-year average) · Operating margin 9.3% · Revenue (TTM) €19.7M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 30 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and 70% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −12% fair-value upside, at −7%, HAIDE screens cheaper than that median.

Fair Value models

Bear €0.7800 Fair Value €1.09 Bull €1.56
Price €1.17 · Downside -6.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Owner Earnings €0.8900 €1.09 €1.41 75
EV/EBITDA €0.7700 €1.31 €1.86 62
NCAV (Graham) €0.7800 €1.05 €1.56 51
All 3 models by family
DCF Models
Owner Earnings €0.8900 €1.09 €1.41 75
Multiples
EV/EBITDA €0.7700 €1.31 €1.86 62
Asset-Based
NCAV (Graham) €0.7800 €1.05 €1.56 51

Open the full fair value analysis →

Quality Score breakdown

Overall quality 54/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 19
How much profit the company makes from its sales and capital
Quality Growth 85
Are margins and returns getting better?
Cashflow 8
Do the profits arrive as real cash?
Financial strength 49
Debt, balance sheet and risk of trouble
Investment 98
Does it invest with discipline instead of growing at any price?
Low Volatility 54
How calm the share price moves, does not count
Price momentum 77
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 77
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+8.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.3%
Start year 2020 (pandemic). Over 10 years: +0.1% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−8.8% (2020) → −0.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch HAIDE, get fair value alerts →

Compare Haidemenos S.A. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 229 stocks

Beats the industry median on 5/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 54 · Below median
Fair Value upside −6.8% · Below median
Profitability
Return on equity (12 months) 4.8% · Below median
Return on assets −1.5% · Bottom 25%
Net margin (12 months) 3.3% · Below median
Operating margin (12 months) 9.3% · Above median
Growth and dividend
Revenue growth (quarter YoY) 20.5% · Top 25%

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/B 0.75× · Cheapest 25%
P/S (12 months) 0.50× · Cheapest 25%
EV/EBITDA 4.9× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)24 · sector 45
FUTURE (revenue growth)100 · sector 33
PAST (return on equity)19 · sector 38
HEALTH (low debt)0 · sector 94
DIVIDEND (yield)0 · sector 57

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Copart, Inc CPRT $31.95 $35.15 +10% vs HAIDE
RB Global, Inc RBA C$131.85 C$145.04 +10% vs HAIDE
Wolters Kluwer N.V WKL €90.08 €98.05 +9% vs HAIDE
Global Payments Inc GPN $97.40 $87.83 −10% vs HAIDE
Brambles Limited BXB A$21.79 A$19.10 −12% vs HAIDE
Cintas Corporation CTAS $222.36 $188.90 −15% vs HAIDE
Rentokil Initial plc RTO $23.61 $19.63 −17% vs HAIDE
Thomson Reuters Corporation TRI $112.57 $70.75 −37% vs HAIDE
Aramark ARMK $52.54 $23.04 −56% vs HAIDE
UL Solutions Inc ULS $78.65 $33.46 −57% vs HAIDE

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Haidemenos S.A.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Haidemenos S.A. Fair Value". https://www.fairvalue-calculator.com/stock/HAIDE

Frequently asked questions

Is Haidemenos S.A. (HAIDE) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of €1.09 versus a price of €1.17, about 7% lower (fairly valued).
What is the fair value of HAIDE?
Our model-based fair value for Haidemenos S.A. is €1.09 (as of Nov 4, 2026), built from audited fundamentals. The current price: €1.17.
What is the quality score of HAIDE?
Haidemenos S.A. has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Haidemenos S.A. (HAIDE)?
Our model-based price target is the fair value of €1.09 (as of Nov 4, 2026) from 3 valuation models. Cautious scenario €0.7800, optimistic scenario €1.56. It is a calculation from audited fundamentals, not an analyst target.
What is the Haidemenos S.A. stock forecast for 2026?
Our models put fair value at €1.09, about 7% lower versus a price of €1.17 (fairly valued). Cautious scenario €0.7800, optimistic scenario €1.56. The calculation is refreshed regularly with new filings.
What is the revenue of Haidemenos S.A. (HAIDE)?
Haidemenos S.A. reported trailing-twelve-month revenue of about €19.7M (latest available figure, as of Nov 4, 2026).
What is the intrinsic value of Haidemenos S.A. (HAIDE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Haidemenos S.A. it is €1.09 per share (as of Nov 4, 2026), against a price of €1.17. It is the blended result of 3 valuation models in 3 families (DCF Models, Multiples, Asset-Based).
Is Haidemenos S.A. stock overvalued or undervalued in 2026?
As of Nov 4, 2026, HAIDE trades above its calculated fair value: price €1.17, fair value €1.09, a gap of about −7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HAIDE?
No. The price is what the market pays today (€1.17); the fair value is what the company's own numbers justify (€1.09). For Haidemenos S.A. the two are €0.0800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Haidemenos S.A. worth?
The market values Haidemenos S.A. at about €9.8M (market capitalisation, as of Nov 4, 2026). Per share that is €1.17; our models calculate a fair value of €1.09 per share.
What do the bullish and bearish scenarios say about HAIDE?
Our models span a range for Haidemenos S.A.: cautious scenario €0.7800, base €1.09, optimistic €1.56 per share (as of Nov 4, 2026, price €1.17). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Haidemenos S.A. (HAIDE)?
Balance-sheet figures for Haidemenos S.A. (as of Nov 4, 2026): return on equity 4.8%. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is HAIDE from its 52-week high?
Haidemenos S.A. trades at €1.17, at its 52-week high of €1.17 and 70% above the low of €0.6900 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €1.09 is for.
Which stocks are comparable to Haidemenos S.A.?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Haidemenos S.A. stock attractive at the current price?
The data as of Nov 4, 2026: price €1.17, calculated fair value €1.09 (−7%), Quality Score 54/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HAIDE calculated?
We run Haidemenos S.A. through 3 models from 3 families: DCF Models, Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of €1.09 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Haidemenos S.A. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Haidemenos S.A. (HAIDE)?
The closing price on Nov 6, 2026 was €1.17. Our model-based fair value is €1.09, about 7% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Haidemenos S.A. right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (€0.7800 to €1.56) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Haidemenos S.A.

How large is the market capitalisation of Haidemenos S.A. (HAIDE)?
The market capitalisation of Haidemenos S.A. is €9.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Haidemenos S.A. (HAIDE)?
The price-to-sales ratio of Haidemenos S.A. is 0.41 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Haidemenos S.A. (HAIDE)?
Earnings per share at Haidemenos S.A. are €−0.1540. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Haidemenos S.A. (HAIDE)?
The net margin of Haidemenos S.A. is −2.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Haidemenos S.A. (HAIDE)?
The return on equity (ROE) of Haidemenos S.A. is 4.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Haidemenos S.A. (HAIDE)?
On an EBIT basis the return on assets of Haidemenos S.A. is −2.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Haidemenos S.A. (HAIDE)?
The operating margin of Haidemenos S.A. is 9.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Haidemenos S.A. (HAIDE)?
Revenue at Haidemenos S.A. is growing +20.5% versus a year earlier (3y avg +0.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Haidemenos S.A. (HAIDE) generate?
The free cash flow of Haidemenos S.A. is −€441K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Haidemenos S.A. (HAIDE) carry?
The net debt of Haidemenos S.A. is €7.1M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Haidemenos S.A. in the live analysis

One click puts Haidemenos S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.